3091-45 — ETOPOSIDE CAPSULES

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

3091-45: ETOPOSIDE CAPSULES.

The ETOPOSIDE CAPSULES is a the manufacturer industrial component. Key specifications include features_provided: INDIVIDUALLY SEALED, primary_container_type: STRIP, protective_storage_feature: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, active_medicament_medicinal_strength: 50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ETOPOSIDE CAPSULES 50MG I.S. 20S PG, capsule_primary_container_content_quantity: 20.000.

This part is cataloged in the U.S. Government catalog under NSN 6505-01-278-1124, indicating validated use in U.S. government and defense logistics supply chains.

Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

3091-45

NSN: 6505-01-278-1124
FSC: 6505 — Drugs and Biologicals
CAGE: 29398 — MEAD JOHNSON & COMPANY, LLC (USA)

SPECIFICATIONS

features_provided	INDIVIDUALLY SEALED
primary_container_type	STRIP
protective_storage_feature	ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
active_medicament_medicinal_strength	50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	ETOPOSIDE CAPSULES 50MG I.S. 20S PG
capsule_primary_container_content_quantity	20.000
NSN	6505-01-278-1124

COMPONENT DIAGRAM

KEY FEATURES

•

FEATURES PROVIDED: INDIVIDUALLY SEALED

•

PRIMARY CONTAINER TYPE: STRIP

•

PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING

•

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 20.000

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

FEATURES PROVIDED	INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE	STRIP
PROTECTIVE STORAGE FEATURE	ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY	20.000
PART NAME ASSIGNED BY CONTROLLING AGENCY	ETOPOSIDE CAPSULES 50MG I.S. 20S PG
ACTIVE MEDICAMENT MEDICINAL STRENGTH	50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 4

VEPESID 50 MG CAPSULASSame NSN cross-reference

Same NSN cross-reference

Also cataloged under this NSN

VEPESID CAPSULESReference document

Same NSN cross-reference

Reference document — Secondary reference

VEPESIDReference document

Same NSN cross-reference

Reference document — Secondary reference

19-001-3117Reference document

Same NSN cross-reference

Reference document — Informative reference only

LIFECYCLE

NSN statusActive· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedNo demilitarization required

Ready to buy 3091-45?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is 3091-45?

3091-45 is a ETOPOSIDE CAPSULES.

What parts can replace 3091-45?

There are 4 known substitutes for 3091-45: VEPESID 50 MG CAPSULAS, VEPESID CAPSULES, VEPESID and 1 more. Substitute compatibility should be verified for your specific system.

What is the NSN for 3091-45?

3091-45 is cataloged in the U.S. Government catalog under NSN 6505-01-278-1124. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

3091-45 — ETOPOSIDE CAPSULES

Request a Quote — 3091-45